We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Breath Ketone Analyzer Accurately Detects Ketosis in Type 1 Diabetes

By LabMedica International staff writers
Posted on 30 Sep 2021
Print article
Image: The Ketonix Breath Ketone Analyzer may be considered as a non-invasive screening tool to rule out ketosis in adults with type 1 diabetes (Photo courtesy of Ketonix)
Image: The Ketonix Breath Ketone Analyzer may be considered as a non-invasive screening tool to rule out ketosis in adults with type 1 diabetes (Photo courtesy of Ketonix)
The presence of high levels of ketones in the bloodstream is a common complication of diabetes, which if left untreated can lead to ketoacidosis. Ketones build up when there is insufficient insulin to help fuel the body’s cells.

High levels of ketones are more common in people with type 1 diabetes (T1D) or people with advanced type 2 diabetes. The most accurate way of testing for ketones is to use a blood glucose meter which can test for ketones as well as blood glucose levels. Urine can be tested for ketone levels; however, the testing of urine means that the level is representative of the ketone levels up to a few hours ago.

Medical Scientists at the University of Colorado (Aurora, CO, USA) assessed the accuracy of a breath ketone analyzer to detect ketosis in adults and children with type 1 diabetes. They analyzed data from adults and children aged 6 years or older that had type 1 diabetes for at least a year. Participants were given a breath ketone analyzer (Ketonix, Varberg, Sweden) and a blood ketone meter (Precision Xtra, Abbott Diabetes Care, Alameda, CA, USA) to measure ketones for 90 days. For 90 days, participants were asked to check ketones at least once daily, if their blood glucose was more than 300 mg/dL, or if they were having diabetic ketoacidosis symptoms. Measurements taken in the morning were considered fasting measurements, whereas all others were considered non-fasting.

The investigators reported that a total of 500 measurements from 19 adults and children with type 1 diabetes were analyzed. There was a significant association between the breath ketone analyzer and blood ketone meter results in non-fasting adults, but not in children. In adults, a cut-off of 3.9 PPM on the breath ketone analyzer maximized the Youden Index with an AUC of 0.73. This cut-off for the breath ketone analyzer had 94.7% sensitivity and 54.2% specificity to detect ketosis (≥0.6 mmol/L in blood ketone meter).

Halis Kaan Akturk, MD, an Endocrinologist and senior author of the study, said, “We found that morning fasting results in adults can be falsely higher in some individuals. We also included some adults with type 1 diabetes using SGLT2 inhibitors that already have higher ketone levels at baseline. A breath ketone analyzer can be a good screening tool in patients that are at high risk for ketosis.”

The authors concluded that the breath ketone analyzer may be considered as a non-invasive screening tool to rule out ketosis in adults with type 1 diabetes. The study was published on August 27, 2021 in the Journal of Diabetes and its Complications.

Related Links:
University of Colorado
Ketonix
Abbott Diabetes Care


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.